Renal failure: A risk factor for methotrexate toxicity

Arthritis and Rheumatism

Volumn 43, Issue 5, 2000, Pages 1185-1186

  Chatham, W Winn ^a   Morgan, Sarah L ^a   Alarcón, Graciela S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; FOLIC ACID; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; BONE MARROW TOXICITY; CASE REPORT; FEMALE; HUMAN; KIDNEY FAILURE; MALE; MYOSITIS; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR;

BONE MARROW DISEASES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METHOTREXATE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 0034081801     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200005)43:5<1185::AID-ANR30>3.0.CO;2-V     Document Type: Article

References (10)

1. Alarcón GS. Methotrexate: its use for the treatment of rheumatoid arthritis and other rheumatic disorders. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 679-98.
2. Bruyn GA, Velthuysen E, Joosten P, Houtman PM. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon? J Rheumatol 1995;22:1373-6.
3. Rheumatoid Arthritis Clinical Trial Archive Group. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 1995;22:218-23.
4. Gutierrez-Uren̂a S, Molina JF, García CO, Cuéllar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:272-6.
5. Berthelot J, Maugars Y, Hamidou M, Chiffoleau A, Barrier J, Gorolleau J, et al. Pancytopenia and severe cytopenia induced by low-dose methotrexate: eight case-reports and a review of one hundred eases from the literature (with twenty-four deaths). Rev Rhum Engl Ed 1995;62:477-86.
6. Mayall B, Poggi G, Parkin JD. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may he fatal. Med J Aust 1991;155:480-4.
7. Physicians Desk Reference. Methotrexate sodium tablets, methotrexate sodium for injection, methotrexate LPF sodium, and methotrexate sodium injection. 53rd ed. Montvale (NJ): Medical Economics; 1999. p. 1397-401.
8. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:723-31.
9. Wall SM, Johansen MJ, Molony DA, DuBose TD Jr, Jaffe N, Madden T. Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis 1996;28:846-54.
10. Ahmad S, Shen FH, Bleyer WA. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med 1978;138:1146-7.